Judging from past reports I'd say it's a pretty good bet that revenue from non-PI sources will continue to grow, which de-risks the company a bit in my opinion.
-Expecting WIP from various class actions to have grown quite well. Some larger cases expected to be resolved within the next year (pelvic mesh, etc)
-Similar if not only slightly improved dividend, debt levels similar ( no significant acquisitions, less earnout outgoings)
- Slight increase in cash flow
+ Hopefully no significant bad press or write downs due to new accounting standards.
Ann: FY18 Half Year Results Announcement Date, page-46
-
- There are more pages in this discussion • 202 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SHJ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
86.5¢ |
Change
-0.005(0.57%) |
Mkt cap ! $144.2M | |||
| Open | High | Low | Value | Volume |
| 87.0¢ | 88.0¢ | 86.5¢ | $46.29K | 52.61K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 14962 | 86.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 87.0¢ | 4339 | 1 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| SHJ (ASX) Chart |
